Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. Avarbock
Inhibitors of Type II NADH:menaquinone Oxidoreductase Represent a Class of Antitubercular Drugs
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Kinase Inhibitors: A New Class of Antirheumatic Drugs
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Steady-State Kinetics and Inhibitory Action of Antitubercular Phenothiazines onMycobacterium tuberculosisType-II NADH-Menaquinone Oxidoreductase (NDH-2)
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
New Antitubercular Drugs Designed by Molecular Modification
Synthetic Inhibitors of Ras Palmitoylation: Defining a Novel Class of Drugs Targeting Breast Cancers
Synergistic Interactions of MmpL3 Inhibitors With Antitubercular Compounds in Vitro
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
L-Type Calcium Channel Gating Modifiers as a New Class of Antiarrhythmic Drugs
Biophysical Journal
Biophysics
A New Class of Antidepressant Drugs in the Treatment of Psychiatric Disorders: The Triple Reuptake Inhibitors
Class II and IV HDACs Function as Inhibitors of Osteoclast Differentiation
PLoS ONE
Multidisciplinary